LI
LianBio
LIANY · OTC
$0.04 +0.00% (+$0.00)
1M -14.06%
Market Cap $4.14M
P/E Ratio 0.84x
Div. Yield -
ROE -
Bulios Fair Price
$0.04
5.5% upside
Current Price
$0.038
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LIANY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/FCF 0.84x
P/E 0.84x
PEG 0.01x
Growth
0 /100
Declining Book val. growth 57.11%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
21 /100
Poor Asset turnover 0.00x
ROIC 6.19%
ROA 23.93%
Debt
100 /100
Low Current ratio 1,466.01x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
11 /100
Unstable Profitable years 3
Beta 0.07x
EPS volatility 241.61%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LIANY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adam Leo Stone
Employees
163
Headquarters
Princeton
Upcoming events
17 NOV
Earnings
Upcoming earnings report